Axcan axcan.com


Public lists: Pharma Startups (4743)

Axcan is a specialty pharmaceutical company focused on development and commercialization of drugs for diseases of the digestive system

Axcan is a specialty pharmaceutical company focused on development and commercialization of drugs for diseases of the digestive system

Company (Alive / Active)

Phone: 450-467-5138

Fax:

597 Laurier Boulevard
Mont-Saint-Hilaire, J3H 6C4
Quebec, Canada

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Axcan $10M Aug 16, 1999
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Axcan Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Targacept

Winston-Salem, North Carolina, United States
IPO / Went publicTargacept is a biopharmaceutical company advancing NNR Therapeutics for the treatment of various diseases and disorders. The company's NNR Therapeutics selectively target neuronal nicotinic receptors, or NNRs. NNRs are found on nerve cells throughout the nervous system and serve as key regulators of nervous system activity.Login to see details

Barrier Therapeutics

Princeton, New Jersey, United States
AcquiredBarrier Therapeutics is a specialty pharmaceutical company focused on development and commercialization of dermatology drugsLogin to see details
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Mesalamine suppository Oct 03, 2008 Jun 02, 2009 Patent